| Human chimeric antigen receptor macrophages for cancer immunotherapy M Klichinsky, M Ruella, O Shestova, XM Lu, A Best, M Zeeman, ... Nature biotechnology 38 (8), 947-953, 2020 | 944 | 2020 |
| Macrophage-based approaches for cancer immunotherapy NR Anderson, NG Minutolo, S Gill, M Klichinsky Cancer research 81 (5), 1201-1208, 2021 | 441 | 2021 |
| Embryonic fibroblasts enable the culture of primary ovarian follicles within alginate hydrogels D Tagler, T Tu, RM Smith, NR Anderson, CM Tingen, TK Woodruff, ... Tissue Engineering Part A 18 (11-12), 1229-1238, 2012 | 81 | 2012 |
| The direction of migration of T-lymphocytes under flow depends upon which adhesion receptors are engaged GA Dominguez, NR Anderson, DA Hammer Integrative Biology 7 (3), 345-355, 2015 | 48 | 2015 |
| Methods to evaluate cell growth, viability, and response to treatment in a tissue engineered breast cancer model KF Goliwas, JR Richter, HC Pruitt, LM Araysi, NR Anderson, RS Samant, ... Scientific reports 7 (1), 14167, 2017 | 39 | 2017 |
| Human neutrophils will crawl upstream on ICAM-1 if Mac-1 is blocked A Buffone, NR Anderson, DA Hammer Biophysical journal 117 (8), 1393-1404, 2019 | 37 | 2019 |
| Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells A Buffone Jr, NR Anderson, DA Hammer Journal of cell science 131 (1), jcs205575, 2018 | 36 | 2018 |
| Supplemented αMEM/F12‐based medium enables the survival and growth of primary ovarian follicles encapsulated in alginate hydrogels D Tagler, Y Makanji, NR Anderson, TK Woodruff, LD Shea Biotechnology and bioengineering 110 (12), 3258-3268, 2013 | 34 | 2013 |
| T lymphocytes migrate upstream after completing the leukocyte adhesion cascade NR Anderson, A Buffone Jr, DA Hammer Cell Adhesion & Migration 13 (1), 164-169, 2019 | 24 | 2019 |
| Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling NR Anderson, V Sheth, H Li, MW Harris, S Qiu, DK Crossman, H Kumar, ... Leukemia 37 (3), 560-570, 2023 | 11 | 2023 |
| Motile dendritic cells sense and respond to substrate geometry AC Bendell, N Anderson, D Blumenthal, EK Williamson, CS Chen, ... Annals of biomedical engineering 46, 1348-1361, 2018 | 9 | 2018 |
| Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition S Qiu, H Kumar, C Yan, H Li, AJ Paterson, NR Anderson, J He, J Yang, ... Leukemia 36 (11), 2621-2633, 2022 | 8 | 2022 |
| Constructs for chimeric antigen receptors M Klichinsky, NG Minutolo, NR Anderson US Patent 11,312,939, 2022 | 8 | 2022 |
| Novel constructs for chimeric antigen receptors M Klichinsky, NG Minutolo, NR Anderson US Patent App. 17/477,491, 2022 | 7 | 2022 |
| SIRPα-Deficient CAR-Macrophages Exhibit Enhanced Anti-Tumor Function and Bypass the CD47 Immune Checkpoint C Sloas, R Gabbasov, NR Anderson, S Abramson, M Klichinsky, Y Ohtani Poster Presentation. Society for Immunotherapy of Cancer (SITC) Meeting …, 2021 | 7 | 2021 |
| Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor M Klichinsky, NG Minutolo, NR Anderson US Patent 11,739,297, 2023 | 6 | 2023 |
| Role of enhanced autophagy in resistance of FLT3-ITD AML stem cells to FLT3 TKI treatment S Qiu, AJ Paterson, A Abraham, J He, M Shah, P Agarwal, AK Mullen, H Li, ... Blood 132, 1358, 2018 | 6 | 2018 |
| A simulation of the random and directed motion of dendritic cells in chemokine fields A Parr, NR Anderson, DA Hammer PLoS Computational Biology 15 (10), e1007295, 2019 | 5 | 2019 |
| An Experimentally Determined State Diagram for Human CD4+ T Lymphocyte CXCR4-Stimulated Adhesion Under Shear Flow NR Anderson, D Lee, DA Hammer Cellular and molecular bioengineering 11, 91-98, 2018 | 5 | 2018 |
| 194 Pre-clinical development of CT-1119, a mesothelin targeting chimeric antigen receptor macrophage (CAR-M), for solid tumor immunotherapy N Anderson, M Klichinsky, K Ciccaglione, S Pierini, B Shah, A Worth, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
